$MRK Headlines Health-care sector taking a broad

New Post Public Reply Private Reply Replies (0) Message Board

Jan 9, 2015 at 10:08 AM

$MRK Headlines

Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co.: Cubist Pharma purchase is a 35% premium to shareholders 7:03 a.m. Dec. 8, 2014 - Carla Mozee
Merck to pay $102 a share for Cubist 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore

FDA clears Daiichi-Sankyo anticoagulant 7:55 p.m. Jan. 8, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 1:00 p.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Merck in 2015 10:44 a.m. Jan. 8, 2015 - 247WallSt.com
Trade-Ideas: Merck (MRK) Is Today's Momo Momentum Stock 9:49 a.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Johnson & Johnson in 2015 7:24 a.m. Jan. 8, 2015 - 247WallSt.com
5 Potential Blockbuster Drugs Set To Launch In 2015 7:02 a.m. Jan. 8, 2015 - Investors Business Daily
Meredith Acquires Selectable Media, Boosts Digital Portfolio - Analyst Blog 4:09 p.m. Jan. 7, 2015 - Zacks.com
The 4 Stocks That Lifted the DJIA on Wednesday 3:17 p.m. Jan. 7, 2015 - 247WallSt.com
CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog 2:16 p.m. Jan. 7, 2015 - Zacks.com
Pfizer: Seems Like The Right Time To Buy 1:51 p.m. Jan. 7, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 12:00 p.m. Jan. 7, 2015 - TheStreet.com
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers 5:39 p.m. Jan. 6, 2015 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Higher 2:00 p.m. Jan. 6, 2015 - TheStreet.com
3 Drugs Stocks On The Rise 12:10 p.m. Jan. 6, 2015 - TheStreet.com
5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List 8:10 a.m. Jan. 6, 2015 - 247WallSt.com
Dow Dividend Dogs: Yahoo Finds 2.83% Edge For 5 Lowest Price High Yield January 2 Issues 7:46 a.m. Jan. 6, 2015 - Seeking Alpha
J&J Starts Human Tests of Ebola Vaccine 6:57 a.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Dow Dividend Dogs: Arbitrage Finds .32% Advantage For 5 Lowest-Priced, High-Yield January 2 Issues 1:21 a.m. Jan. 6, 2015 - Seeking Alpha
A Dozen Dow Dividend Dogs Dance About 9% To 20% Upsides Into January 12:43 a.m. Jan. 6, 2015 - Seeking Alpha

Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 22 min ago - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Today - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Today - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE
REPEAT - EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:02 a.m. Jan. 5, 2015 - Marketwired
Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 8:00 a.m. Jan. 5, 2015 - BusinessWire - BZX
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck 12:29 p.m. Dec. 22, 2014 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VISTAR Oakland Workers Join Teamsters for Unity

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Nomada Fund Launches: A Game-Changer in New Media

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

D2L Ventures into Vietnam with Van Lang Alliance

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Community Heritage Financial Declares Q3 2026 Dividend

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Kenneth Smith Takes Helm for Trends Int’l Expansion

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Standex's New Financial Lead: Stoddard Takes Helm

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...